ENOV — Enovis CORP
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1420800 ·
Last close
$25.75
Market Cap
$1.48B
52W High
$27.89
52W Low
$19.14
ADV30
1,233,668
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 589,151,000 | 365,485,000 | 9,238,000 | -8,764,000 | 3,832,256,000 | 33,129,000 | 2,352,764,000 |
| Dec 2025 | 575,758,000 | 349,421,000 | 48,254,000 | -520,589,000 | 3,834,737,000 | 36,389,000 | 2,342,835,000 |
| Sep 2025 | 548,912,000 | 328,913,000 | -8,136,000 | -571,146,000 | 4,433,367,000 | 33,617,000 | 2,409,689,000 |
| Jun 2025 | 564,545,000 | 334,697,000 | -16,080,000 | -36,739,000 | 5,021,398,000 | 44,074,000 | 2,440,438,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$217,293,000
Investing CF
$-179,371,000
Financing CF
$-52,400,000
CapEx
$-197,376,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-20.71
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,467,463,000
Inventory
$584,379,000
Receivables
$442,786,000
ST Investments
—
EBIT TTM
$-1,124,595,000
Pretax Income TTM
$-1,159,418,000
Interest Exp TTM
$34,823,000
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,278,365,952
EBITDA
$372,248,992
Free Cash Flow
$206,902,368
Enterprise Value
$2,831,691,776
Total Cash
$33,129,000
Total Debt
$1,410,520,960
Shares Out
57,562,603
Trailing EPS
$-19.89
Book Value
$25.66
ROE
-55.3%
ROA
1.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,248,049,000 | -18,869,000 | -1,184,440,000 | 3,834,737,000 | 2,342,835,000 | — | 217,293,000 |
| Dec 2024 | 2,107,623,000 | -103,429,000 | -825,494,000 | 4,718,777,000 | 2,154,448,000 | — | 113,504,000 |
| Dec 2023 | 1,707,197,000 | -48,374,000 | -33,261,000 | 4,509,334,000 | 1,088,633,000 | — | 134,988,000 |
| Dec 2022 | 1,563,101,000 | -90,658,000 | -13,292,000 | 4,273,248,000 | 823,447,000 | — | -55,861,000 |
TTM Snapshot
Revenues TTM
$1,666,483,000
NetIncome TTM
$-75,165,000
OpCashFlow TTM
$0
Assets (Latest)
$4,718,777,000
Forward EPS
$4.08
Max Pain — expiry 2026-07-17
max pain strike: $25.00 · spot: $25.75 · call oi: 3,274 · put oi: 1,560
Expected Move to 2026-07-17:
±$2.75
(10.68%) —
implied range
$23.00 –
$28.50
· ATM straddle on $25.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATEC | Alphatec Holdings, Inc. | $1.47B | $9.58 | — |
| INSP | Inspire Medical Systems, Inc. | $1.49B | $51.76 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.46B | $18.79 | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.52B | $25.99 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.38B | $28.18 | — |
News headlines (Yahoo Finance, 1h cache)
Why Enovis (ENOV) Stock Is Trading Up Today
2026-07-06 23:16 · Yahoo
4 Top Growth Stocks Worth Buying Under $100 Today
2026-07-03 12:50 · Yahoo
1 Oversold Stock Primed to Rebound and 2 We Find Risky
2026-06-24 10:16 · Yahoo
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1
2026-06-11 17:21 · Yahoo
Assessing Enovis (ENOV) Valuation After Recent Share Price Weakness
2026-06-11 16:18 · Yahoo
CD&R Engages Former Enovis CEO as Operating Advisor
2026-06-11 11:00 · Yahoo
Brookdale Senior May 2026 Occupancy Volume Rises to 82.5%
2026-06-09 17:14 · Yahoo
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
2026-06-09 16:20 · Yahoo
Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?
2026-06-09 13:25 · Yahoo
How The Investment Story For Enovis (ENOV) Is Evolving Without New Analyst Targets
2026-06-09 01:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.